Sept 24 (Reuters) - Spectral AI Inc :
* SPECTRAL AI ACHIEVES 25% PATIENT ENROLLMENT AT EMERGENCY DEPARTMENTS FOR U.S. BURN PIVOTAL STUDY AND ADDS TWO NEW CLINICAL TRIAL SITES
* SPECTRAL AI INC - PARTICIPATING EDS EXPANDED TO 11 FACILITIES
* SPECTRAL AI INC - FDA SUBMISSION EXPECTED IN Q2 2025
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.